SELECTION AND CHARACTERIZATION OF CEFEPIME-RESISTANT GRAM-NEGATIVE BACTERIA

被引:17
|
作者
PIDDOCK, LJV
GRIGGS, DJ
机构
[1] Antimicrobial Agents Research Group, Department of Medical Microbiology, The Medical School, University of Birmingham
关键词
D O I
10.1093/jac/28.5.669
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The NCTC type strains and four clinical isolates of Enterobacter cloacae, Citrobacter freundii, Serratia marcescens, Morganella morganii, Providencia stuartii and Pseudomonas aeruginosa were exposed, in agar, to cefepime at 3, 5, and 10 × MIC and a breakpoint concentration of 16 mg/L. Mutants were selected at a frequency of ̃ 10-2 that had decreased susceptibility to cefepime and cefpirome, and species-dependent resistance to other β-lactams. Any putative mutant with a greater than four-fold increase in the MIC was examined to determine its β-lactamase expression and outer membrane protein (Omp) profile. Mutant strains of P. stuartii and M. morganii lacked an Omp of molecular mass similar to that of OmpF, and were cross-resistant to nalidixic acid. Mutant strains of E. cloacae had derepressed class I β-lactamase production and lacked an Omp corresponding to OmpF, suggesting that in this species both parameters are necessary for decreased susceptibility. Derepressed β-lactamases purified from mutant strains of E. cloacae, C. freundii and P. stuartii was able to hydrolyse cefepime, but not as quickly as TEM-10. © 1991, by The British Society for Antimicrobial Chemotherapy.
引用
收藏
页码:669 / 676
页数:8
相关论文
共 50 条
  • [31] Essential oils against multidrug resistant gram-negative bacteria
    Buckova, Maria
    Puskarova, Andrea
    Kalaszova, Viktoria
    Kisova, Zuzana
    Pangallo, Domenico
    BIOLOGIA, 2018, 73 (08) : 803 - 808
  • [32] Combination therapy for carbapenem-resistant Gram-negative bacteria
    Paul, Mical
    Carmeli, Yehuda
    Durante-Mangoni, Emanuele
    Mouton, Johan W.
    Tacconelli, Evelina
    Theuretzbacher, Ursula
    Mussini, Cristina
    Leibovici, Leonard
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (09) : 2305 - 2309
  • [33] Multidrug-resistant Gram-negative bacteria: a product of globalization
    Hawkey, P. M.
    JOURNAL OF HOSPITAL INFECTION, 2015, 89 (04) : 241 - 247
  • [34] Current concepts in antibiotic-resistant Gram-negative bacteria
    Torres, Julian Andres
    Villegas, Maria Virginia
    Quinn, Andjohn P.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2007, 5 (05) : 833 - 843
  • [35] Multidrug-Resistant Gram-Negative Bacteria in Burn Patients
    Ruegsegger, Laura
    Xiao, Jamie
    Naziripour, Arash
    Kanumuambidi, Trey
    Brown, Dylan
    Williams, Felicia
    Marshall, Steven H.
    Rudin, Susan D.
    Yen, Kelly
    Chu, Tingyu
    Chen, Liang
    Sozzi, Emanuele
    Bartelt, Luther
    Kreiswirth, Barry
    Bonomo, Robert A.
    van Duin, David
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (09)
  • [36] Worldwide proliferation of carbapenem-resistant gram-negative bacteria
    Kurokawa, H
    Yagi, T
    Shibata, N
    Shibayama, K
    Arakawa, Y
    LANCET, 1999, 354 (9182): : 955 - 955
  • [37] Updates in the Management of Cephalosporin-Resistant Gram-Negative Bacteria
    Andre Arizpe
    Kelly R. Reveles
    Shrina D. Patel
    Samuel L. Aitken
    Current Infectious Disease Reports, 2016, 18
  • [38] Conundrums in the laboratory detection of antimicrobial resistant Gram-negative bacteria
    Schreckenberger, PC
    REVIEWS IN MEDICAL MICROBIOLOGY, 2004, 15 (02) : 45 - 49
  • [39] Combination therapy for carbapenem-resistant Gram-negative bacteria
    Zavascki, Alexandre P.
    Bulitta, Jurgen B.
    Landersdorfer, Cornelia B.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2013, 11 (12) : 1333 - 1353
  • [40] The global threat of carbapenem-resistant gram-negative bacteria
    Dropa, Milena
    Daoud, Ziad
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12